Preferred Label : Anti-GD3 Antibody-drug Conjugate PF-06688992;
NCIt synonyms : GD3 ADC PF-06688992; Anti-GD3 ADC PF-06688992;
NCIt related terms : PF-06688992;
NCIt definition : An antibody-drug conjugate (ADC) composed of a monoclonal antibody against the ganglioside
GD3, a surface antigen expressed on many malignant melanoma cells, and linked to an
as of yet not fully elucidated chemotherapeutic agent, with potential antineoplastic
activity. Upon administration of the ADC PF-06688992, the antibody moiety targets
and binds to GD3 expressed on melanoma cells. Upon internalization, the chemotherapeutic
agent specifically kills the GD3-positive cells. GD3 represents a major surface marker
on most human melanoma cells and is not expressed on most other types of normal, healthy
cells.;
UNII : X6L6R3CFT8;
CAS number : 2249791-21-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2249791-21-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Molecule name : PF 06688992; PF-06688992;
NCI Metathesaurus CUI : CL523729;
Origin ID : C136426;
UMLS CUI : C4526672;
Semantic type(s)
- concept_is_in_subset
- has_target
